Patient Safety Incidents in Coordinated Primary Care Teams: a Multi-method Study (EVIDENS-Prim)

January 19, 2024 updated by: Nantes University Hospital

In France, improving the practice of health professionals working in coordinated primary care teams (health centres called Maisons de Santé Pluriprofessionnelles - MSPs) could be facilitated by a learning system consisting of (i) a risk management support programme and (ii) the provision of a comprehensive online system combining training, reporting and support for the analysis and management of patient safety incidents (PSIs).

EVIDENS-Prim is a multi-method, multi-centre, prospective study. It aims to describe the PSIs that occur in MSPs, using an international classification system, and to describe the ways in which professionals have adopted a global approach to PSIs management, from PSI reporting to feedback.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This method combines:

- (i) A sequential study of PSIs analysis. The sequential study will take place in three stages (coder training, collection of PSIs data via the web platform, PSIs coding).

Each PSIs reported by professionals during the implementation of the risk management support programme will be coded using the PISA multi-axial classification system (based on the WHO's International Classification for Patient Safety in Primary Care). These codes will be used to describe PSIs in coordinated practice.

- (ii) An implementation study of the learning system. The learning system is described in the intervention section. During the implementation study, two types of data collection (quantitative and qualitative) will be mobilised at the end of the support to the QualiREL Santé Regional Support Structure.

The main objective of the study is:

- To Describe PSIs occurring in MSPs as part of the coordinated exercise and over an 18-month period, according to the 4 coding frameworks of the PISA classification: (i) types of events (main and contributing), (ii) contributing factors, (iii) outcomes of PSIs, (iv) severity of harm.

The secondary objectives, linked to the evaluation of the implementation of the learning system, are

  • To examine the acceptance of the learning system by the teams,
  • To describe the effective use of the web platform by professionals,
  • To describe the MSP's ownership of the risk management support programme.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Characteristics of the MSPs included in the study:
  • Located in the Pays de la Loire region;
  • Having a contract with a health insurance (specifications and financing defined nationally) for at least 1 year;
  • Agreeing to take part in the project;
  • Having a quality representative or committing to appoint one when they join the project.

Characteristics of professionals working in MSPs included:

  • All independent health professionals involved in the MSP: general practitioners and, depending on the MSP, nurses, pharmacists, podiatrists, physiotherapists, midwives, speech therapists, dentists, occupational therapists, psychomotor therapists, etc,)
  • All professionals involved in MSP outside the health sector: (coordinators, medical assistants, independent psychologists, etc.),
  • agree to take part in the project.

Exclusion Criteria:

Other group exercise modalities or other forms of coordinated exercise (other than MSP) do not have a quality representative on their team and will not be considered for inclusion.

Characteristics of MSPs not included in the research:

- Where the members of the research team work.

Characteristics of professionals working in MSPs included:

- Not included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Learning system benefits MSPs
MSPs benefit from a learning system (described in the intervention section). MSPs are encouraged to report PSIs through the web platform provided after the initial training in each MSP and during the period of methodological support.
MSPs benefit from a learning system. The learning system combines an individualised support programme provided by a regional support structure for quality and safety in health care (QualiREL Santé) and the provision of a web platform. Based on the 4 dimensions of the Shortell model, the support programme includes initial training (6 months) and personalised methodological support (18 months) for each MSP. A web platform is provided to MSPs to enable them to implement the full approach of the Risk Management Support Programme. It provides support for reporting, analysis and management of PSIs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 1-by type
Time Frame: PSIs reported by MSP professionals in the 18 months following the initial training provided
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by type: the number of PSIs for each type out of the total number of PSIs reported.
PSIs reported by MSP professionals in the 18 months following the initial training provided
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 2- by contributing factors
Time Frame: 18 months
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by contributing factors : number of PSIs for each contributing factor (e.g. factors related to the patient, staff, equipment, organisation, etc.) out of the total number of PSIs reported.
18 months
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 3-by results
Time Frame: 18 months
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by results: number of PSIs for each result (no harm, clinical harm, team harm) out of the total number of PSIs reported.
18 months
Distribution of PSIs occurring in MSPs according to the 4 coding frameworks of the PISA classification: 4-by severity
Time Frame: 18 months
Repartition, according to the PISA classification, of PSIs reported by MSP professionals in the 18 months following the initial training provided, by severity: number of PSIs of each severity (e.g. no harm, mild, moderate or severe harm, death) out of the total number of PSIs reported.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of MSP professionals' acceptance of learning system
Time Frame: 3 months
Analysis of the main themes and sub-themes of the acceptability of the learning system from the semi-directed interviews and focus groups conducted with MSP professionals.
3 months
Description of the behaviour of users of the online system in the 18 months following the provision of initial training
Time Frame: 18 months

Export from the web platform of

  • the number of professionals who have validated the opening of their account on the web platform,
  • the number of professionals who have declared at least one PSI,
  • the number of modifications made to the PSIs declaration,
  • the number of declarations in anonymous mode,
  • the number of updates of action sheets corresponding to improvement actions.
18 months
Description of the MSP's behaviour in implementing the risk management support programme during the 18 months following the provision of the initial training.
Time Frame: 18 months

Description: Export from the web platform of

  • the number of PSI declarations
  • the number of systemic analyses of PSIs carried out,
  • the number of types of contributing factors identified by the analysis (variable categories defined according to the analysis methods),
  • the number of analyses identifying security barriers (by type: present and effective / present and ineffective / absent),
  • the number of improvement actions planned / completed / abandoned.
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

January 19, 2024

First Submitted That Met QC Criteria

January 19, 2024

First Posted (Actual)

January 30, 2024

Study Record Updates

Last Update Posted (Actual)

January 30, 2024

Last Update Submitted That Met QC Criteria

January 19, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RC23_0402
  • RSP22N005 (Other Grant/Funding Number: French Ministry of Health: Direction générale offre de soins)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adverse Event

Clinical Trials on Health Services Research

3
Subscribe